title: Italian experience with AutoCapture in conjunction with a membrane lead. Pacesetter Automatic Control of Energy and Membrane Automatic Threshold Evaluation (Pacemate) Study Group.
abstract: AutoCapture is a programmable feature of the Pacesetter Microny SR + 2425T VVIR pacemaker, which provides for the automatic capture verification, increase in output in the presence of noncapture and threshold searching, with adjustment of output settings. The effectiveness of this unit in conjunction with the Membrane models 1400T and 1401T bipolar endocardial leads was studied in 54 patients followed at 19 Italian Centers. The patients were randomized at the time of implantation to receive either the model 1400T or the 1401T lead. The electrodes in these leads are covered by a Nafion membrane, which was either impregnated (model 1400T) or not-impregnated (model 1401T) with steroid. This paper reports the data collected over the first six weeks postimplantation. The results of the automatic capture function was compared to the capture threshold measured using the Vario technique at the time of predischarge evaluations, and weeks 1,2, and 6 of postimplant follow-up. The reliability and effectiveness of the pulse generator-lead system allowed for consistent pacing at very low outputs and safety preserved at a programmed output only 0.3 V above the capture threshold.
authors.affiliation: Department of Cardiology, Ospedale Infermi, Rimini, Italy.
authors.forename: S
authors.initials: S
authors.lastname: Sermasi
authors.forename: M
authors.initials: M
authors.lastname: Marconi
authors.forename: L
authors.initials: L
authors.lastname: Libero
authors.forename: P V
authors.initials: PV
authors.lastname: Moracchini
authors.forename: L
authors.initials: L
authors.lastname: Rusconi
authors.forename: A
authors.initials: A
authors.lastname: Mininno
authors.forename: R
authors.initials: R
authors.lastname: Sigliano
mesh_terms: D000368:Aged; D000704:Analysis of Variance; D001281:Atrial Fibrillation / Q000628:therapy; D002304:Cardiac Pacing, Artificial / Q000379:methods*; D003692:Delayed-Action Preparations; D003907:Dexamethasone / Q000008:administration & dosage / Q000627:therapeutic use; D004567:Electrodes, Implanted; D004867:Equipment Design; D004869:Equipment Safety; D005260:Female; D005465:Fluorocarbon Polymers; D005500:Follow-Up Studies; D006327:Heart Block / Q000628:therapy; D006801:Humans; D007474:Ion Exchange; D007558:Italy; D008297:Male; D008567:Membranes, Artificial; D010138:Pacemaker, Artificial; D015203:Reproducibility of Results; D012984:Software
chemical_list: D003692:Delayed-Action Preparations; D005465:Fluorocarbon Polymers; D008567:Membranes, Artificial; C040402:perfluorosulfonic acid; D003907:Dexamethasone